Managing abusive patients – legal and regulatory considerations for pharmacists

A C+D investigation has revealed that pharmacy teams are increasingly facing abuse and even violence from patients. What should pharmacy professionals consider when handling these situations?

"A pharmacist can refuse to supply an NHS prescription if threatened with violence"

According to C+D’s recent investigation, in 2021 alone, violent crime – which includes violence against a person, public order offences, arson and criminal damage – accounted for 13.4% of all crimes in pharmacies reported in Northern Ireland, 18.1% of all crimes in England and a staggering 20.5% of all crimes in pharmacies reported in Wales.

Free to registered users

Register to gain full access to C+D and C+D Community content

Sign in or register for free

Latest from Analysis

Why I’ve launched a campaign against the RPS’s planned changes

 
• By 
 • comment

‘Vote no’ campaigner Martin Astbury tells C+D why he believes the RPS plans for change represent a shift away from pharmacist leadership and why members should vote against them this week…

CPE is negotiating in a very difficult and nuanced environment that few will have experienced

 
• By 
 • comment

I also read comments that CPE does not appreciate this critical position, and I fundamentally refute that. Knowing the colleagues, both elected and employed, at CPE as I do, this is far from the case.

It’s not just funding delays holding pharmacy back, it’s the old dinosaurs too...

 
• By 
 • comment

Community pharmacy is risk adverse, considered, and dare I say it, conservative. But, when it comes to the survival of pharmacy, we can’t afford to let the fear of change – or those resistant to it - hold us back.

More from Business

breaking news

IN FULL: Boots’ parent company sold in $24bn private equity deal

 
• By 
 • comment8

Walgreens Boots Alliance (WBA) has “entered into a definitive agreement to be acquired” by private equity firm Sycamore Partners.

Jhoots accounts: Shareholder funds tumble while debts soar

 
• By 
 • comment2

Jhoots Chemist’s accounts for 2024 have revealed an almost £2 million year-on-year dip in shareholder funds – as debts to creditors increase more than £2m.